Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial. Stinchcombe TE. J Clin Oncol 2023;41:1159-1160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stinchcombe TE. Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial. J Clin Oncol 2023;41:1159-1160.
PMID: 36791472